Acadia Pharmaceuticals Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+17.5% +$11M
$74M
Free Cash Flow↓-110.0% -$44M
$-4M
Investing Cash Flow↓-783.6% -$110M
$-124M
Financing Cash Flow↑+1051.1% +$21M
$23M
Capex↑+784.1% +$4M
$4M
Stock-Based Comp↑+26.7% +$3M
$13M
Debt Repaid
—
D&A↓-10.6% -$24K
$202K
SBC Allocated Expense↑+26.7% +$3M
$13M
SBC Unrecognized Cost
—